COVID Vaccination

Coronavirus is still spreading in India and around the world, with more than 10 million confirmed cases and 0.15 million deaths in India till Feb-2021. According to the Ministry of Health, more than 20% of the Indian population is at risk of getting severe Health symptoms and possible death risk due to the COVID-19 Virus. A handful of vaccines now have been authorized around the globe and more than 260 are under development. Below is the chart of 9 vaccines.

S. No.	Product	Manufacturer	Collaborator
1	Covishield	Serum Institute of India, Pune	Astra Zeneca
2	Covaxin (inactivated Virus)	Bharat Biotech International Ltd., Hyderabad	Indian Council of medical Research, India
3	ZyCoV-D (DNA Vaccine)	Cadila Healthcare Ltd., Ahmedabad (Zyduc Cadila)	Dept. of Biotechnology, India
4	Sputnik-V (Human Adenovirus Vaccine)	Trialed & Manufactured in India by Dr. Reddy’s Lab	Gamaleya National Center, Russia
5	NXV-CoV2373	Serum Institute of India, Pune	Novavax
6	Recombinant Protein Antigen based Vaccine	Biological E Ltd., Hyderabad	MIT, USA
7	HGCO 19 (mRNA based vaccine)	Genova	HDT, USA
8	Inactived Rabies vector platform	Bharat Biotech International Ltd., Hyderabad	Thomas Jefferson University, USA
9	Vesiculo Vax Platform	Aurobindo Pharma Ltd., Hyderabad	Aurovaccine, USA

Current Govt. Guidelines on
Covid Administration

Two-dose schedule to be administered two, three or four weeks apart, and need to be administered through the intramuscular route.
National Expert Group on Vaccine Administration for COVID19 (NEGVAC) will be the administrating authority in India & publish all the guidelines from time to time
The COVID-19 vaccine will be offered:

First to healthcare workers, frontline workers and to persons above 50 years of age.
Followed by persons younger than 50 years of age with associated comorbidities based on evolving pandemic situation.
And finally to the remaining population based on the disease epidemiology and vaccine availability.

The priority group of above 50 years may be further subdivided into those above 60 years of age and those between 50 to 60 years of age for purposes of phasing of roll out based on pandemic situation and vaccine availability.

Vaccinator Officer– Doctors (MBBS/BDS), Staff nurse, Pharmacist, ANM, LHV; anyone legally authorized to give injection may be considered as a potential vaccinator.
Vaccination Officer 1: At least one person (Police, home guard, Civil defense, NCC, NSS, NYK) who will check registration status of beneficiary at the entry point and ensure guarded entry to the vaccination session.
Vaccination Officer 2: is the verifier who will authenticate/verify the identification documents;
Vaccination Officer 3 & 4 are the two-support staff who will be responsible for crowd management, IEC/communication and support to vaccinator.

Safety precautions, including infection prevention and control practices, safe injection practices and waste disposal, will be followed during the vaccination sessions. As large population groups will be vaccinated over a short period of time with a new vaccine, monitoring the safety of these vaccines will be critical. The existing adverse event following immunization (AEFI) surveillance system will be utilized to monitor adverse events and inform the understanding of the safety profile of the vaccines. To ensure confidence in the vaccine and the immunization programme during COVID-19 vaccine introduction, states/UTs must rapidly detect and promptly respond to all AEFIs. The reporting of AEFI through SAFEVAC is being integrated with Co-WIN software and every AEFI to be reported at the district level and further the referral mechanisms in case of any AEFI needs to be put in place.

Preparations Needed to Administer COVID Vaccine in Private Space

COVID Vaccine Administration Process

Operating Model with Clients & Partners

Comparison between COVISHIELD™ Vs COVAXIN™

COVID Vaccination

Current Govt. Guidelines on Covid Administration

Current Govt. Guidelines on
Covid Administration